CTI 223 Pill — WHITE OVAL, 18mm — Ciprofloxacin
| Imprint | CTI / 223 |
|---|---|
| Colour | WHITE |
| Shape | OVAL |
| Size | 18 |
| Strength | CIPROFLOXACIN HYDROCHLORIDE 500 mg |
| Dosage form | Tablet, Film Coated |
| Manufacturer | Liberty Pharmaceuticals, Inc. |
| NDC | 0440-6291 |
| Schedule | — |
| Availability | — |
| Ingredients | CIPROFLOXACIN HYDROCHLORIDE[CIPROFLOXACIN] |
What does this imprint mean?
The imprint "CTI 223" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ciprofloxacin
Uses and warnings
BOXED WARNING: BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Risk of tendon rupture (especially Achilles tendon), particularly in patients over 60, on corticosteroids, or with organ transplants - Peripheral neuropathy with potentially irreversible symptoms - CNS effects: psychiatric reactions, seizures, hallucinations, depression with suicidal ideation - Serious hypersensitivity/anaphylactic reactions possible - Hepatotoxicity including fatal hepatic failure reported - QT interval prolongation and torsade de pointes risk - Aortic aneurysm and dissection risk in elderly patients - C. difficile-associated diarrhea possible | BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Ris
Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18+ years) and select pediatric patients for treating infections including: skin/skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax post-exposure, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, and acute sinusitis. The label emphasizes reserving use for patients with no alternative treatment options for certain conditions like acute uncomplicated cystitis and acute bronchitis exacerbations due to serious adverse risks.
How to identify this pill
- • Check the imprint matches exactly: "CTI 223".
- • Confirm the colour (WHITE) and shape (OVAL).
- • Compare the size (18) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
225 IG
WHITE OVAL · Gemfibrozil
E 01
WHITE OVAL · Carvedilol
M365
WHITE OVAL · Hydrocodone
AN70
WHITE OVAL · Alendronate
875
WHITE OVAL · Pramipexole
Y102
WHITE OVAL · Ciprofloxacin
3169 V
WHITE OVAL · Furosemide
2266 V
WHITE OVAL · Baclofen
ip 109
WHITE OVAL · Hydrocodone
3592 V
WHITE OVAL · Hydrocodone
139
WHITE OVAL · Naproxen
AC 356
WHITE OVAL · Doxazosin
Other pills of Ciprofloxacin
Y102
WHITE OVAL · Ciprofloxacin
WW929
WHITE CAPSULE · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
APO CIP
WHITE ROUND · Ciprofloxacin
R 127
WHITE OVAL · Ciprofloxacin
CR 500
WHITE OVAL · Ciprofloxacin
CTI 222
WHITE ROUND · Ciprofloxacin
CR 500
WHITE OVAL · Ciprofloxacin
P 250
WHITE ROUND · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
WW927
WHITE ROUND · Ciprofloxacin
R 126
WHITE OVAL · Ciprofloxacin
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file fa6108be-f4de-41b6-991a-902414a8548a.xml